Highland Capital Management released its quarterly 13F report for 2015 in the first week of the year. According to this report, this hedge fund firm has a portfolio value of over $3.42 billion. There has been a decrease of $1.49 billion from $4.91 billion the previous quarter. This represents a change in market value of -30.41 %. The firm had a total turnover percentage of 22.37 %. The statistics in this report represent about 22.73% of the assets listed in the United States by Highland Capital Management.
The report indicates that this firm was able to acquire new positions at Spdr S&P 500 Etf Tr (Call) (SPY) for $67.07 million, Amazon Com Inc (AMZN) for $23.35 million and Eagle Pharmaceuticals Inc (EGRX) for $17.73 million. Other new positions were acquired in Danaher Corp Del (DHR) for $17.24 million and Intra Cellular Therapies Inc (ITCI) for $15.90 million. These companies represent the top 5 new positions from total o 69 new stocks acquired by the firm. Highland Capital Management acquired 1.96% in Spdr S&P 500 Etf Tr (Call), 0.68% in Amazon Com Inc, 0.52% in Eagle Pharmaceuticals Inc, 0.50% in Danaher Corp Del and 0.46% in Intra Cellular Therapies Inc.
According to the report, the firm spread investments in all sectors of the economy. The top five sectors in allocation include health care with 20 %, information technology with 18 %, finance with 18 %, energy with 12 % and consumer discretionary 10 %.
James Dondero is the co-founder and president of Highland Capital Management, a Dallas-based investment firm. Jim has worked for over 30 years in the credit and equity markets, and James has been able to gain a lot of experience. His practice was majorly focused largely on high-yield and distressed investment solutions.
Jim has helped Highland Capital to launch into the Collateralized Loan Obligation (CLO) market. He is also known for introducing credit-oriented solutions for institutional and retail investors globally. He has also played a major role in innovative products like institutional separate accounts, CLOs, hedge funds, private equity funds, mutual funds, REITs and ETFs, some of which ave won major awards.